{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:44:15Z","timestamp":1791726255350,"version":"4.3.4"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T00:00:00Z","timestamp":1505347200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s10549-017-4488-x","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T05:32:18Z","timestamp":1505367138000},"page":"9-29","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Molecular profile of atypical hyperplasia of the breast"],"prefix":"10.1007","volume":"167","author":[{"given":"David N.","family":"Danforth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,14]]},"reference":[{"issue":"11","key":"4488_CR1","first-page":"2698","volume":"55","author":"DL Page","year":"1985","unstructured":"Page DL, Dupont WD, Rogers LW, Rados MS (1985) Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55(11):2698\u20132708","journal-title":"A long-term follow-up study. Cancer"},{"issue":"9352","key":"4488_CR2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(03)12230-1","volume":"361","author":"DL Page","year":"2003","unstructured":"Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD Jr, Simpson JF (2003) Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 361(9352):125\u2013129","journal-title":"Lancet"},{"issue":"1\u20132","key":"4488_CR3","first-page":"107","volume":"424","author":"D Roy","year":"1999","unstructured":"Roy D, Liehr JG (1999) Estrogen. DNA damage and mutations. Mutat Res 424(1\u20132):107\u2013115","journal-title":"DNA damage and mutations. Mutat Res"},{"issue":"19","key":"4488_CR4","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1200\/JCO.2006.09.0217","volume":"25","author":"AC Degnim","year":"2007","unstructured":"Degnim AC, Visscher DW, Berman HK, Frost MH, Sellers TA, Vierkant RA, Maloney SD, Pankratz VS, de Groen PC, Lingle WL, Ghosh K, Penheiter L, Tlsty T, Melton LJ III, Reynolds CA, Hartmann LC (2007) Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol 25(19):2671\u20132677","journal-title":"J Clin Oncol"},{"issue":"1","key":"4488_CR5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJMsr1407164","volume":"372","author":"LC Hartmann","year":"2015","unstructured":"Hartmann LC, Degnim AC, Santen RJ, Dupont WD, Ghosh K (2015) Atypical hyperplasia of the breast\u2013risk assessment and management options. N Engl J Med 372(1):78\u201389","journal-title":"N Engl J Med"},{"issue":"12","key":"4488_CR6","first-page":"1249","volume":"114","author":"JD Crissman","year":"1990","unstructured":"Crissman JD, Visscher DW, Kubus J (1990) Image cytophotometric DNA analysis of atypical hyperplasias and intraductal carcinomas of the breast. Arch Pathol Lab Med 114(12):1249\u20131253","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"4488_CR7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00109-008-0408-1","volume":"87","author":"Y Gao","year":"2009","unstructured":"Gao Y, Niu Y, Wang X, Wei L, Lu S (2009) Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridization. J Mol Med 87(2):145\u2013152","journal-title":"J Mol Med"},{"issue":"10","key":"4488_CR8","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1158\/1055-9965.EPI-08-0821","volume":"18","author":"MO Hoque","year":"2009","unstructured":"Hoque MO, Prencipe M, Poeta ML, Barbano R, Valori VM, Copetti M, Gallo AP, Brait M, Maiello E, Apicella A, Rossiello R, Zito F, Stefania T, Paradiso A, Carella M, Dallapiccola B, Murgo R, Carosi I, Bisceglia M, Fazio VM, Sidransky D, Parrella P (2009) Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression. Cancer Epidemiol Biomarkers Prev 18(10):2694\u20132700","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"4488_CR9","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1073\/pnas.0931261100","volume":"100","author":"XJ Ma","year":"2003","unstructured":"Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P, Payette T, Pistone M, Stecker K, Zhang BM, Zhou YX, Varnholt H, Smith B, Gadd M, Chatfield E, Kessler J, Baer TM, Erlander MG, Sgroi DC (2003) Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA 100(10):5974\u20135979","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"4488_CR10","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/cncr.27841","volume":"119","author":"MP Murray","year":"2013","unstructured":"Murray MP, Luedtke C, Liberman L, Nehhozina T, Akram M, Brogi E (2013) Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision. Cancer 119(5):1073\u20131079. doi: 10.1002\/cncr.27841","journal-title":"Cancer"},{"issue":"10","key":"4488_CR11","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1245\/s10434-012-2534-9","volume":"19","author":"MG Shah-Khan","year":"2012","unstructured":"Shah-Khan MG, Geiger XJ, Reynolds C, Jakub JW, Deperi ER, Glazebrook KN (2012) Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia\/lobular carcinoma in situ) diagnosed on core needle biopsy. Ann Surg Oncol 19(10):3131\u20133138. doi: 10.1245\/s10434-012-2534-9","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"4488_CR12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/(SICI)1096-9896(199907)188:3<237::AID-PATH343>3.0.CO;2-8","volume":"188","author":"BS Shoker","year":"1999","unstructured":"Shoker BS, Jarvis C, Sibson DR, Walker C, Sloane JP (1999) Oestrogen receptor expression in the normal and pre-cancerous breast. J Pathol 188(3):237\u2013244","journal-title":"J Pathol"},{"issue":"22","key":"4488_CR13","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1093\/jnci\/dji372","volume":"97","author":"B Fisher","year":"2005","unstructured":"Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N (2005) Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 97(22):1652\u20131662. doi: 10.1093\/jnci\/dji372","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"4488_CR14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0046-8177(88)80350-2","volume":"19","author":"DL Page","year":"1988","unstructured":"Page DL, Dupont WD, Rogers LW (1988) Ductal involvement by cells of atypical lobular hyperplasia in the breast: a long-term follow-up study of cancer risk. Hum Pathol 19(2):201\u2013207","journal-title":"Hum Pathol"},{"issue":"12","key":"4488_CR15","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00000478-199212000-00001","volume":"16","author":"SJ Schnitt","year":"1992","unstructured":"Schnitt SJ, Connolly JL, Tavassoli FA, Fechner RE, Kempson RL, Gelman R, Page DL (1992) Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol 16(12):1133\u20131143","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"4488_CR16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0046-8177(96)90104-5","volume":"27","author":"N Sneige","year":"1996","unstructured":"Sneige N, Sahin A, Dinh M, El Naggar A (1996) Interphase cytogenetics in mammographically detected breast lesions. Hum Pathol 27(4):330\u2013335","journal-title":"Hum Pathol"},{"issue":"1","key":"4488_CR17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/modpathol.3880485","volume":"15","author":"L Mariuzzi","year":"2002","unstructured":"Mariuzzi L, Mombello A, Granchelli G, Rucco V, Tarocco E, Frank D, Davis J, Thompson D, Bartels H, Mariuzzi GM, Bartels PH (2002) Quantitative study of breast cancer progression: different pathways for various in situ cancers. Mod Pathol 15(1):18\u201325","journal-title":"Mod Pathol"},{"issue":"4A","key":"4488_CR18","first-page":"1953","volume":"16","author":"D Stefano Di","year":"1996","unstructured":"Di Stefano D, Scucchi L, Limiti MR, Mingazzini PL, Marinozzi V (1996) Modifications of interphasic NORs as a diagnostic parameter of atypical lesions of the female breast. Anticancer Res 16(4A):1953\u20131961","journal-title":"Anticancer Res"},{"issue":"3","key":"4488_CR19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/path.1711760305","volume":"176","author":"FC Schmitt","year":"1995","unstructured":"Schmitt FC, Leal C, Lopes C (1995) p53 protein expression and nuclear DNA content in breast intraductal proliferations. J Pathol 176(3):233\u2013241","journal-title":"J Pathol"},{"issue":"1","key":"4488_CR20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0046-8177(94)90167-8","volume":"25","author":"MA Micale","year":"1994","unstructured":"Micale MA, Visscher DW, Gulino SE, Wolman SR (1994) Chromosomal aneuploidy in proliferative breast disease. Hum Pathol 25(1):29\u201335","journal-title":"Hum Pathol"},{"issue":"3","key":"4488_CR21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10549-008-0029-y","volume":"114","author":"Q Yu","year":"2009","unstructured":"Yu Q, Niu Y, Yu Y, Ding X, Shi Y (2009) Analysis of the progression of intraductal proliferative lesions in the breast by PCR-based clonal assay. Breast Cancer Res Treat 114(3):433\u2013440","journal-title":"Breast Cancer Res Treat"},{"key":"4488_CR22","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/0046-8177(92)90056-9","volume":"23","author":"E Eriksson","year":"1992","unstructured":"Eriksson E, Schimmelpenning H, Silfversward C, Auer G (1992) Immunoreactivity with monoclonal antibody A-80 and nuclear DNA content in benign and malignant human breast disease. Hum Pathol 23:1366\u20131372","journal-title":"Hum Pathol"},{"issue":"6","key":"4488_CR23","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1054\/bjoc.1999.1064","volume":"82","author":"MC Cummings","year":"2000","unstructured":"Cummings MC, Aubele M, Mattis A, Purdie D, Hutzler P, Hofler H, Werner M (2000) Increasing chromosome 1 copy number parallels histological progression in breast carcinogenesis. Br J Cancer 82(6):1204\u20131210","journal-title":"Br J Cancer"},{"issue":"7015","key":"4488_CR24","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature03099","volume":"432","author":"H Rajagopalan","year":"2004","unstructured":"Rajagopalan H, Lengauer C (2004) Aneuploidy and cancer. Nature 432(7015):338\u2013341","journal-title":"Nature"},{"issue":"7","key":"4488_CR25","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.bbagrm.2012.02.020","volume":"1819","author":"T Ried","year":"2012","unstructured":"Ried T, Hu Y, Difilippantonio MJ, Ghadimi BM, Grade M, Camps J (2012) The consequences of chromosomal aneuploidy on the transcriptome of cancer cells. Biochim Biophys Acta 1819(7):784\u2013793","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"4488_CR26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/embor.2012.65","volume":"13","author":"SJ Pfau","year":"2012","unstructured":"Pfau SJ, Amon A (2012) Chromosomal instability and aneuploidy in cancer: from yeast to man. EMBO Rep 13(6):515\u2013527","journal-title":"EMBO Rep"},{"issue":"4","key":"4488_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/35070129","volume":"3","author":"R Fodde","year":"2001","unstructured":"Fodde R, Kuipers J, Rosenberg C, Smits R, Kielman M, Gaspar C, van Es JH, Breukel C, Wiegant J, Giles RH, Clevers H (2001) Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 3(4):433\u2013438. doi: 10.1038\/35070129","journal-title":"Nat Cell Biol"},{"issue":"1","key":"4488_CR28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ng1282","volume":"36","author":"G Liu","year":"2004","unstructured":"Liu G, Parant JM, Lang G, Chau P, Chavez-Reyes A, El-Naggar AK, Multani A, Chang S, Lozano G (2004) Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Nat Genet 36(1):63\u201368","journal-title":"Nat Genet"},{"issue":"3","key":"4488_CR29","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1371\/journal.pbio.0040051","volume":"4","author":"KM McDermott","year":"2006","unstructured":"McDermott KM, Zhang J, Holst CR, Kozakiewicz BK, Singla V, Tlsty TD (2006) p16(INK4a) prevents centrosome dysfunction and genomic instability in primary cells. PLoS Biol 4(3):e51","journal-title":"PLoS Biol"},{"issue":"10","key":"4488_CR30","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nrc1714","volume":"5","author":"GJ Kops","year":"2005","unstructured":"Kops GJ, Weaver BA, Cleveland DW (2005) On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 5(10):773\u2013785","journal-title":"Nat Rev Cancer"},{"key":"4488_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4137\/bcbcr.s39384","volume":"10","author":"DN Danforth Jr","year":"2016","unstructured":"Danforth DN Jr (2016) Genomic changes in normal breast tissue in women at normal risk or at high risk for breast cancer. Breast Cancer 10:109\u2013146. doi: 10.4137\/bcbcr.s39384","journal-title":"Breast Cancer"},{"issue":"3","key":"4488_CR32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/path.1973","volume":"209","author":"PS Larson","year":"2006","unstructured":"Larson PS, de las MA, Cerda SR, Bennett SR, Cupples LA, Rosenberg CL (2006) Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors. J Pathol 209(3):307\u2013316","journal-title":"J Pathol"},{"issue":"5","key":"4488_CR33","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1172\/JCI118890","volume":"98","author":"CL Rosenberg","year":"1996","unstructured":"Rosenberg CL, de las MA, Huang K, Cupples LA, Faller DV, Larson PS (1996) Detection of monoclonal microsatellite alterations in atypical breast hyperplasia. J Clin Invest 98(5):1095\u20131100","journal-title":"J Clin Invest"},{"issue":"6","key":"4488_CR34","first-page":"1277","volume":"6","author":"M Amari","year":"1999","unstructured":"Amari M, Suzuki A, Moriya T, Yoshinaga K, Amano G, Sasano H, Ohuchi N, Satomi S, Horii A (1999) LOH analyses of premalignant and malignant lesions of human breast: frequent LOH in 8p, 16q, and 17q in atypical ductal hyperplasia. Oncol Rep 6(6):1277\u20131280","journal-title":"Oncol Rep"},{"issue":"8","key":"4488_CR35","first-page":"2410","volume":"7","author":"G Gong","year":"2001","unstructured":"Gong G, DeVries S, Chew KL, Cha I, Ljung BM, Waldman FM (2001) Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization. Clin Cancer Res 7(8):2410\u20132414","journal-title":"Clin Cancer Res"},{"issue":"6820","key":"4488_CR36","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/35054579","volume":"409","author":"SR Romanov","year":"2001","unstructured":"Romanov SR, Kozakiewicz BK, Holst CR, Stampfer MR, Haupt LM, Tlsty TD (2001) Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 409(6820):633\u2013637","journal-title":"Nature"},{"issue":"5","key":"4488_CR37","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1073\/pnas.051625398","volume":"98","author":"S Thiagalingam","year":"2001","unstructured":"Thiagalingam S, Laken S, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B, Lengauer C (2001) Mechanisms underlying losses of heterozygosity in human colorectal cancers. Proc Natl Acad Sci USA 98(5):2698\u20132702","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"4488_CR38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/jhg.2009.35","volume":"54","author":"H Kurahashi","year":"2009","unstructured":"Kurahashi H, Bolor H, Kato T, Kogo H, Tsutsumi M, Inagaki H, Ohye T (2009) Recent advance in our understanding of the molecular nature of chromosomal abnormalities. J Hum Genet 54(5):253\u2013260. doi: 10.1038\/jhg.2009.35","journal-title":"J Hum Genet"},{"issue":"2","key":"4488_CR39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","volume":"340","author":"LC Hartmann","year":"1999","unstructured":"Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340(2):77\u201384","journal-title":"N Engl J Med"},{"issue":"1","key":"4488_CR40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57\u201370","journal-title":"Cell"},{"issue":"35","key":"4488_CR41","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1038\/sj.onc.1205606","volume":"21","author":"M Widschwendter","year":"2002","unstructured":"Widschwendter M, Jones PA (2002) DNA methylation and breast carcinogenesis. Oncogene 21(35):5462\u20135482","journal-title":"Oncogene"},{"key":"4488_CR42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/path.2541","volume":"218","author":"D Zou","year":"2009","unstructured":"Zou D, Yoon HS, Perez D, Weeks RJ, Guilford P, Humar B (2009) Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia. J Pathol 218:265\u2013272","journal-title":"J Pathol"},{"issue":"1","key":"4488_CR43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00428-010-1013-6","volume":"458","author":"SY Park","year":"2011","unstructured":"Park SY, Kwon HJ, Lee HE, Ryu HS, Kim SW, Kim JH, Kim IA, Jung N, Cho NY, Kang GH (2011) Promoter CpG island hypermethylation during breast cancer progression. Virchows Arch 458(1):73\u201384","journal-title":"Virchows Arch"},{"issue":"2","key":"4488_CR44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10549-009-0534-7","volume":"121","author":"M Santisteban","year":"2010","unstructured":"Santisteban M, Reynolds C, Barr Fritcher EG, Frost MH, Vierkant RA, Anderson SS, Degnim AC, Visscher DW, Pankratz VS, Hartmann LC (2010) Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia. Breast Cancer Res Treat 121(2):431\u2013437","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"4488_CR45","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s001090100269","volume":"79","author":"JH Kang","year":"2001","unstructured":"Kang JH, Kim SJ, Noh DY, Choe KJ, Lee ES, Kang HS (2001) The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer. J Mol Med (Berlin, Germany) 79(11):648\u2013655. doi: 10.1007\/s001090100269","journal-title":"J Mol Med (Berlin, Germany)"},{"issue":"1","key":"4488_CR46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.canlet.2004.03.010","volume":"212","author":"P Keohavong","year":"2004","unstructured":"Keohavong P, Gao WM, Mady HH, Kanbour-Shakir A, Melhem MF (2004) Analysis of p53 mutations in cells taken from paraffin-embedded tissue sections of ductal carcinoma in situ and atypical ductal hyperplasia of the breast. Cancer Lett 212(1):121\u2013130","journal-title":"Cancer Lett"},{"issue":"6","key":"4488_CR47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s004280050114","volume":"431","author":"BW Lisboa","year":"1997","unstructured":"Lisboa BW, Vogtlander S, Gilster T, Riethdorf L, Milde-Langosch K, Loning T (1997) Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer. Virchows Arch 431(6):375\u2013381","journal-title":"Virchows Arch"},{"issue":"4","key":"4488_CR48","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrm2147","volume":"8","author":"KH Vousden","year":"2007","unstructured":"Vousden KH, Lane DP (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8(4):275\u2013283","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"4488_CR49","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1349-7006.2008.01075.x","volume":"100","author":"Y Niu","year":"2009","unstructured":"Niu Y, Liu T, Tse GM, Sun B, Niu R, Li HM, Wang H, Yang Y, Ye X, Wang Y, Yu Q, Zhang F (2009) Increased expression of centrosomal alpha, gamma-tubulin in atypical ductal hyperplasia and carcinoma of the breast. Cancer Sci 100(4):580\u2013587","journal-title":"Cancer Sci"},{"issue":"1","key":"4488_CR50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1756-9966-29-112","volume":"29","author":"XY Mao","year":"2010","unstructured":"Mao XY, Fan CF, Zheng HC, Wei J, Yao F, Jin F (2010) p53 nuclear accumulation and ERalpha expression in ductal hyperplasia of breast in a cohort of 215 Chinese women. J Exp Clin Cancer Res 29(1):112","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"4488_CR51","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/ajcp\/94.5.533","volume":"94","author":"R Barnes","year":"1990","unstructured":"Barnes R, Masood S (1990) Potential value of hormone receptor assay in carcinoma in situ of breast. Am J Clin Pathol 94(5):533\u2013537","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"4488_CR52","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1158\/0008-5472.CAN-05-4300","volume":"66","author":"L Ding","year":"2006","unstructured":"Ding L, Erdmann C, Chinnaiyan AM, Merajver SD, Kleer CG (2006) Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues. Cancer Res 66(8):4095\u20134099","journal-title":"Cancer Res"},{"issue":"14","key":"4488_CR53","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1128\/MCB.00162-07","volume":"27","author":"B Shi","year":"2007","unstructured":"Shi B, Liang J, Yang X, Wang Y, Zhao Y, Wu H, Sun L, Zhang Y, Chen Y, Li R, Zhang Y, Hong M, Shang Y (2007) Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Mol Cell Biol 27(14):5105\u20135119","journal-title":"Mol Cell Biol"},{"issue":"6","key":"4488_CR54","first-page":"2537","volume":"61","author":"P Roger","year":"2001","unstructured":"Roger P, Sahla ME, Makela S, Gustafsson JA, Baldet P, Rochefort H (2001) Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 61(6):2537\u20132541","journal-title":"Cancer Res"},{"issue":"6","key":"4488_CR55","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00432-014-1652-0","volume":"140","author":"NI Chantzi","year":"2014","unstructured":"Chantzi NI, Palaiologou M, Stylianidou A, Goutas N, Vassilaros S, Kourea HP, Dhimolea E, Mitsiou DJ, Tiniakos DG, Alexis MN (2014) Estrogen receptor beta2 is inversely correlated with Ki-67 in hyperplastic and noninvasive neoplastic breast lesions. J Cancer Res Clin Oncol 140(6):1057\u20131066","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"4488_CR56","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0360-3016(03)00203-7","volume":"56","author":"X Gao","year":"2003","unstructured":"Gao X, Fisher SG, Emami B (2003) Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 56(4):1038\u20131045","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4488_CR57","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/1097-0142(196412)17:12<1501::AID-CNCR2820171202>3.0.CO;2-P","volume":"17","author":"GF Robbins","year":"1964","unstructured":"Robbins GF, Berg JW (1964) Bilateral primary breast cancer: a prospective clincopathological study. Cancer 17:1501\u20131527","journal-title":"Cancer"},{"issue":"6","key":"4488_CR58","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1524-4741.2001.07605.x","volume":"7","author":"RS Samant","year":"2001","unstructured":"Samant RS, Olivotto IA, Jackson JS, Mates D (2001) Diagnosis of metachronous contralateral breast cancer. Breast J 7(6):405\u2013410","journal-title":"Breast J"},{"issue":"3","key":"4488_CR59","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1200\/jco.2009.23.1274","volume":"28","author":"M Dowsett","year":"2010","unstructured":"Dowsett M, Cuzick J, Ingle J, Coates A, Forbes J, Bliss J, Buyse M, Baum M, Buzdar A, Colleoni M, Coombes C, Snowdon C, Gnant M, Jakesz R, Kaufmann M, Boccardo F, Godwin J, Davies C, Peto R (2010) Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol 28(3):509\u2013518. doi: 10.1200\/jco.2009.23.1274","journal-title":"J Clin Oncol"},{"issue":"4","key":"4488_CR60","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9610(00)00451-7","volume":"180","author":"G Adrales","year":"2000","unstructured":"Adrales G, Turk P, Wallace T, Bird R, Norton HJ, Greene F (2000) Is surgical excision necessary for atypical ductal hyperplasia of the breast diagnosed by Mammotome? Am J Surg 180(4):313\u2013315","journal-title":"Am J Surg"},{"issue":"3","key":"4488_CR61","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1148\/radiol.2313040154","volume":"231","author":"MA Cohen","year":"2004","unstructured":"Cohen MA (2004) Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: some reasons why. Radiology 231(3):617\u2013621. doi: 10.1148\/radiol.2313040154","journal-title":"Radiology"},{"issue":"2","key":"4488_CR62","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1148\/radiol.2242011528","volume":"224","author":"RJ Jackman","year":"2002","unstructured":"Jackman RJ, Birdwell RL, Ikeda DM (2002) Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision? Radiology 224(2):548\u2013554. doi: 10.1148\/radiol.2242011528","journal-title":"Radiology"},{"issue":"5","key":"4488_CR63","doi-asserted-by":"publisher","first-page":"W275","DOI":"10.2214\/ajr.07.2165","volume":"189","author":"AP Lourenco","year":"2007","unstructured":"Lourenco AP, Mainiero MB, Lazarus E, Giri D, Schepps B (2007) Stereotactic breast biopsy: comparison of histologic underestimation rates with 11- and 9-gauge vacuum-assisted breast biopsy. Am J Roentgenol 189(5):W275\u2013W279. doi: 10.2214\/ajr.07.2165","journal-title":"Am J Roentgenol"},{"issue":"4","key":"4488_CR64","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.amjsurg.2006.06.003","volume":"192","author":"JA Margenthaler","year":"2006","unstructured":"Margenthaler JA, Duke D, Monsees BS, Barton PT, Clark C, Dietz JR (2006) Correlation between core biopsy and excisional biopsy in breast high-risk lesions. Am J Surg 192(4):534\u2013537. doi: 10.1016\/j.amjsurg.2006.06.003","journal-title":"Am J Surg"},{"issue":"3","key":"4488_CR65","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2214\/ajr.07.2768","volume":"190","author":"RF Brem","year":"2008","unstructured":"Brem RF, Lechner MC, Jackman RJ, Rapelyea JA, Evans WP, Philpotts LE, Hargreaves J, Wasden S (2008) Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. Am J Roentgenol 190(3):637\u2013641. doi: 10.2214\/ajr.07.2768","journal-title":"Am J Roentgenol"},{"issue":"1","key":"4488_CR66","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2214\/ajr.08.1342","volume":"192","author":"PR Eby","year":"2009","unstructured":"Eby PR, Ochsner JE, DeMartini WB, Allison KH, Peacock S, Lehman CD (2009) Frequency and upgrade rates of atypical ductal hyperplasia diagnosed at stereotactic vacuum-assisted breast biopsy: 9-versus 11-gauge. Am J Roentgenol 192(1):229\u2013234. doi: 10.2214\/ajr.08.1342","journal-title":"Am J Roentgenol"},{"issue":"3","key":"4488_CR67","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1148\/radiol.09091406","volume":"255","author":"JR Kohr","year":"2010","unstructured":"Kohr JR, Eby PR, Allison KH, DeMartini WB, Gutierrez RL, Peacock S, Lehman CD (2010) Risk of upgrade of atypical ductal hyperplasia after stereotactic breast biopsy: effects of number of foci and complete removal of calcifications. Radiology 255(3):723\u2013730. doi: 10.1148\/radiol.09091406","journal-title":"Radiology"},{"issue":"6","key":"4488_CR68","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1001\/archsurg.138.6.619","volume":"138","author":"DJ Winchester","year":"2003","unstructured":"Winchester DJ, Bernstein JR, Jeske JM, Nicholson MH, Hahn EA, Goldschmidt RA, Watkin WG, Sener SF, Bilimoria MB, Barrera E, Jr, Winchester DP (2003) Upstaging of atypical ductal hyperplasia after vacuum-assisted 11-gauge stereotactic core needle biopsy. Arch Surg 138(6):619\u2013622. doi: 10.1001\/archsurg.138.6.619","journal-title":"Arch Surg"},{"issue":"2","key":"4488_CR69","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2214\/ajr.11.7212","volume":"198","author":"N Ibrahim","year":"2012","unstructured":"Ibrahim N, Bessissow A, Lalonde L, Mesurolle B, Trop I, Lisbona A, El-Khoury M (2012) Surgical outcome of biopsy-proven lobular neoplasia: is there any difference between lobular carcinoma in situ and atypical lobular hyperplasia? Am J Roentgenol 198(2):288\u2013291. doi: 10.2214\/ajr.11.7212","journal-title":"Am J Roentgenol"},{"issue":"3","key":"4488_CR70","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/1097-0142(19900201)65:3<518::AID-CNCR2820650324>3.0.CO;2-O","volume":"65","author":"FA Tavassoli","year":"1990","unstructured":"Tavassoli FA, Norris HJ (1990) A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 65(3):518\u2013529","journal-title":"Cancer"},{"issue":"4","key":"4488_CR71","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0344-0338(00)80071-0","volume":"196","author":"AF Marinho","year":"2000","unstructured":"Marinho AF, Botelho M, Schmitt FC (2000) Evaluation of numerical abnormalities of chromosomes 1 and 17 in proliferative epithelial breast lesions using fluorescence in situ hybridization. Pathol Res Pract 196(4):227\u2013233","journal-title":"Pathol Res Pract"},{"issue":"5","key":"4488_CR72","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/cncr.20558","volume":"102","author":"S Krishnamurthy","year":"2004","unstructured":"Krishnamurthy S, Zhao L, Hayes K, Glassman AB, Cristofanilli M, Singletary SE, Hunt KK, Kuerer HM, Sneige N (2004) Feasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens: a preliminary study. Cancer 102(5):322\u2013327","journal-title":"Cancer"},{"issue":"2","key":"4488_CR73","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/(SICI)1097-0142(19960115)77:2<315::AID-CNCR14>3.0.CO;2-4","volume":"77","author":"DW Visscher","year":"1996","unstructured":"Visscher DW, Wallis TL, Crissman JD (1996) Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics. Cancer 77(2):315\u2013320","journal-title":"Cancer"},{"issue":"3","key":"4488_CR74","first-page":"291","volume":"4","author":"EB King","year":"1991","unstructured":"King EB, Chew KL, Hom JD, Duarte LA, Mayall B, Miller TR, Neuhaus JM, Wrensch MR, Petrakis NL (1991) Characterization by image cytometry of duct epithelial proliferative disease of the breast. Mod Pathol 4(3):291\u2013296","journal-title":"Mod Pathol"},{"issue":"5","key":"4488_CR75","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF01600515","volume":"420","author":"H Schimmelpenning","year":"1992","unstructured":"Schimmelpenning H, Eriksson ET, Falkmer UG, Azavedo E, Svane G, Auer GU (1992) Expression of the c-erbB-2 proto-oncogene product and nuclear DNA content in benign and malignant human breast parenchyma. Virchows Arch A 420(5):433\u2013440","journal-title":"Virchows Arch A"},{"issue":"11","key":"4488_CR76","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/0046-8177(94)90040-X","volume":"25","author":"ET Eriksson","year":"1994","unstructured":"Eriksson ET, Schimmelpenning H, Aspenblad U, Zetterberg A, Auer GU (1994) Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease. Hum Pathol 25(11):1228\u20131233","journal-title":"Hum Pathol"},{"issue":"10","key":"4488_CR77","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/bjs.1800741011","volume":"74","author":"R Carpenter","year":"1987","unstructured":"Carpenter R, Gibbs N, Matthews J, Cooke T (1987) Importance of cellular DNA content in pre-malignant breast disease and pre-invasive carcinoma of the female breast. Br J Surg 74(10):905\u2013906","journal-title":"Br J Surg"},{"issue":"9","key":"4488_CR78","first-page":"815","volume":"119","author":"FC Schmitt","year":"1995","unstructured":"Schmitt FC, Figueiredo P, Lacerda M (1995) Expression of c-erb B-2 protein and DNA ploidy in breast carcinogenesis. Arch Pathol Lab Med 119(9):815\u2013820","journal-title":"Arch Pathol Lab Med"},{"issue":"15","key":"4488_CR79","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/jnci\/92.15.1217","volume":"92","author":"CJ Fabian","year":"2000","unstructured":"Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Kamel S, Zeiger S, Mayo MS (2000) Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst 92(15):1217\u20131227","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"4488_CR80","first-page":"98","volume":"12","author":"RL Teplitz","year":"1990","unstructured":"Teplitz RL, Butler BB, Tesluk H, Min BH, Russell LA, Jensen HM, Hill LR (1990) Quantitative DNA patterns in human preneoplastic breast lesions. Anal Quant Cytol Histol 12(2):98\u2013102","journal-title":"Anal Quant Cytol Histol"},{"issue":"12","key":"4488_CR81","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/j.1365-2559.1987.tb01875.x","volume":"11","author":"CR Potter De","year":"1987","unstructured":"De Potter CR, Praet MM, Slavin RE, Verbeeck P, Roels HJ (1987) Feulgen DNA content and mitotic activity in proliferative breast disease. A comparison with ductal carcinoma in situ. Histopathology 11(12):1307\u20131319","journal-title":"Histopathology"},{"issue":"1","key":"4488_CR82","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ijc.2910600107","volume":"60","author":"CU Dietrich","year":"1995","unstructured":"Dietrich CU, Pandis N, Teixeira MR, Bardi G, Gerdes AM, Andersen JA, Heim S (1995) Chromosome abnormalities in benign hyperproliferative disorders of epithelial and stromal breast tissue. Int J Cancer 60(1):49\u201353","journal-title":"Int J Cancer"},{"issue":"1","key":"4488_CR83","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00019606-200003000-00003","volume":"9","author":"MM Aubele","year":"2000","unstructured":"Aubele MM, Cummings MC, Mattis AE, Zitzelsberger HF, Walch AK, Kremer M, Hofler H, Werner M (2000) Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer. Diagn Mol Pathol 9(1):14\u201319","journal-title":"Diagn Mol Pathol"},{"issue":"11","key":"4488_CR84","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/gcc.20368","volume":"45","author":"TL Mastracci","year":"2006","unstructured":"Mastracci TL, Shadeo A, Colby SM, Tuck AB, O\u2019Malley FP, Bull SB, Lam WL, Andrulis IL (2006) Genomic alterations in lobular neoplasia: a microarray comparative genomic hybridization signature for early neoplastic proliferationin the breast. Genes Chromosomes Cancer 45(11):1007\u20131017","journal-title":"Genes Chromosomes Cancer"},{"issue":"9","key":"4488_CR85","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/jnci\/90.9.697","volume":"90","author":"P O\u2019Connell","year":"1998","unstructured":"O\u2019Connell P, Pekkel V, Fuqua SA, Osborne CK, Clark GM, Allred DC (1998) Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst 90(9):697\u2013703","journal-title":"J Natl Cancer Inst"},{"issue":"20","key":"4488_CR86","first-page":"4721","volume":"58","author":"YJ Lu","year":"1998","unstructured":"Lu YJ, Osin P, Lakhani SR, Di Palma S, Gusterson BA, Shipley JM (1998) Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 58(20):4721\u20134727","journal-title":"Cancer Res"},{"issue":"4","key":"4488_CR87","first-page":"1422","volume":"6","author":"MG Tibiletti","year":"2000","unstructured":"Tibiletti MG, Sessa F, Bernasconi B, Cerutti R, Broggi B, Furlan D, Acquati F, Bianchi M, Russo A, Capella C, Taramelli R (2000) A large 6q deletion is a common cytogenetic alteration in fibroadenomas, pre-malignant lesions, and carcinomas of the breast. Clin Cancer Res 6(4):1422\u20131431","journal-title":"Clin Cancer Res"},{"issue":"6","key":"4488_CR88","first-page":"1172","volume":"63","author":"N Tidow","year":"2003","unstructured":"Tidow N, Boecker A, Schmidt H, Agelopoulos K, Boecker W, Buerger H, Brandt B (2003) Distinct amplification of an untranslated regulatory sequence in the egfr gene contributes to early steps in breast cancer development. Cancer Res 63(6):1172\u20131178","journal-title":"Cancer Res"},{"issue":"12","key":"4488_CR89","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1245\/ASO.2005.03.522","volume":"12","author":"RE Ellsworth","year":"2005","unstructured":"Ellsworth RE, Ellsworth DL, Deyarmin B, Hoffman LR, Love B, Hooke JA, Shriver CD (2005) Timing of critical genetic changes in human breast disease. Ann Surg Oncol 12(12):1054\u20131060","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4488_CR90","first-page":"297","volume":"150","author":"RF Chuaqui","year":"1997","unstructured":"Chuaqui RF, Zhuang Z, Emmert-Buck MR, Liotta LA, Merino MJ (1997) Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast. Am J Pathol 150(1):297\u2013303","journal-title":"Am J Pathol"},{"issue":"3","key":"4488_CR91","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0046-8177(97)90124-6","volume":"28","author":"R Nayar","year":"1997","unstructured":"Nayar R, Zhuang Z, Merino MJ, Silverberg SG (1997) Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction. Hum Pathol 28(3):277\u2013282","journal-title":"Hum Pathol"},{"issue":"5","key":"4488_CR92","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/modpathol.3880322","volume":"14","author":"H Tsuda","year":"2001","unstructured":"Tsuda H, Takarabe T, Akashi-Tanaka S, Fukutomi T, Hirohashi S (2001) Pattern of chromosome 16q loss differs between an atypical proliferative lesion and an intraductal or invasive ductal carcinoma occurring subsequently in the same area of the breast. Mod Pathol 14(5):382\u2013388","journal-title":"Mod Pathol"},{"issue":"6","key":"4488_CR93","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/modpathol.3800362","volume":"18","author":"TL Mastracci","year":"2005","unstructured":"Mastracci TL, Tjan S, Bane AL, O\u2019Malley FP, Andrulis IL (2005) E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast. Mod Pathol 18(6):741\u2013751","journal-title":"Mod Pathol"},{"issue":"7","key":"4488_CR94","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jcp.48.7.611","volume":"48","author":"SR Lakhani","year":"1995","unstructured":"Lakhani SR, Collins N, Stratton MR, Sloane JP (1995) Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol 48(7):611\u2013615","journal-title":"J Clin Pathol"},{"issue":"1","key":"4488_CR95","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1359-4117.2002.01001.x","volume":"2","author":"M Kaneko","year":"2002","unstructured":"Kaneko M, Arihiro K, Takeshima Y, Fujii S, Inai K (2002) Loss of heterozygosity and microsatellite instability in epithelial hyperplasia of the breast. J Exp Ther Oncol 2(1):9\u201318","journal-title":"J Exp Ther Oncol"},{"issue":"5","key":"4488_CR96","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s004280050429","volume":"435","author":"M Werner","year":"1999","unstructured":"Werner M, Mattis A, Aubele M, Cummings M, Zitzelsberger H, Hutzler P, Hofler H (1999) 20q13.2 amplification in intraductal hyperplasia adjacent to in situ and invasive ductal carcinoma of the breast. Virchows Arch 435(5):469\u2013472","journal-title":"Virchows Arch"},{"issue":"1","key":"4488_CR97","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1158\/1055-9965.EPI-06-0598","volume":"16","author":"GR Bean","year":"2007","unstructured":"Bean GR, Ibarra DC, Goldenberg VK, Baker JC Jr, Troch MM, Paisie C, Wilke LG, Yee L, Marcom PK, Kimler BF, Fabian CJ, Zalles CM, Broadwater G, Scott V, Seewaldt VL (2007) Hypermethylation of the breast cancer-associated gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of breast cancer risk. Cancer Epidemiol Biomarkers Prev 16(1):50\u201356","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9265","key":"4488_CR98","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(00)04501-3","volume":"357","author":"E Evron","year":"2001","unstructured":"Evron E, Dooley WC, Umbricht CB, Rosenthal D, Sacchi N, Gabrielson E, Soito AB, Hung DT, Ljung B, Davidson NE, Sukumar S (2001) Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. Lancet 357(9265):1335\u20131336","journal-title":"Lancet"},{"issue":"26","key":"4488_CR99","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1038\/sj.onc.1204438","volume":"20","author":"CB Umbricht","year":"2001","unstructured":"Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S (2001) Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene 20(26):3348\u20133353","journal-title":"Oncogene"},{"issue":"10","key":"4488_CR100","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1038\/bjc.2013.136","volume":"108","author":"AQ Hoesel van","year":"2013","unstructured":"van Hoesel AQ, Sato Y, Elashoff DA, Turner RR, Giuliano AE, Shamonki JM, Kuppen PJ, van de Velde CJ, Hoon DS (2013) Assessment of DNA methylation status in early stages of breast cancer development. Br J Cancer 108(10):2033\u20132038","journal-title":"Br J Cancer"},{"issue":"3","key":"4488_CR101","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/annonc\/mdn651","volume":"20","author":"T Liu","year":"2009","unstructured":"Liu T, Niu Y, Yu Y, Liu Y, Zhang F (2009) Increased gamma-tubulin expression and P16INK4A promoter methylation occur together in preinvasive lesions and carcinomas of the breast. Ann Oncol 20(3):441\u2013448","journal-title":"Ann Oncol"},{"key":"4488_CR102","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.humpath.2008.04.001","volume":"39","author":"T Liu","year":"2008","unstructured":"Liu T, Niu Y, Feng Y, Niu R, Yu Y, Lv A, Yang Y (2008) Methylation of CpG islands of p16(INK4a) and cyclinD1 overexpression associated with progression of intraductal proliferative lesions of the breast. Hum Pathol 39:1637\u20131646","journal-title":"Hum Pathol"},{"issue":"6","key":"4488_CR103","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/jnci\/djn036","volume":"100","author":"DW Visscher","year":"2008","unstructured":"Visscher DW, Pankratz VS, Santisteban M, Reynolds C, Ristimaki A, Vierkant RA, Lingle WL, Frost MH, Hartmann LC (2008) Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer. J Natl Cancer Inst 100(6):421\u2013427. doi: 10.1093\/jnci\/djn036","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"4488_CR104","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nm1295-1257","volume":"1","author":"D Weinstat-Saslow","year":"1995","unstructured":"Weinstat-Saslow D, Merino MJ, Manrow RE, Lawrence JA, Bluth RF, Wittenbel KD, Simpson JF, Page DL, Steeg PS (1995) Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat Med 1(12):1257\u20131260","journal-title":"Nat Med"},{"issue":"4","key":"4488_CR105","first-page":"847","volume":"4","author":"KM Alle","year":"1998","unstructured":"Alle KM, Henshall SM, Field AS, Sutherland RL (1998) Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. Clin Cancer Res 4(4):847\u2013854","journal-title":"Clin Cancer Res"},{"issue":"11","key":"4488_CR106","first-page":"1082","volume":"11","author":"XL Zhu","year":"1998","unstructured":"Zhu XL, Hartwick W, Rohan T, Kandel R (1998) Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma. Mod Pathol 11(11):1082\u20131088","journal-title":"Mod Pathol"},{"issue":"6","key":"4488_CR107","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1378::AID-CNCR15>3.0.CO;2-I","volume":"88","author":"Z Gatalica","year":"2000","unstructured":"Gatalica Z, Lele SM, Rampy BA, Norris BA (2000) The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma. Cancer 88(6):1378\u20131383","journal-title":"Cancer"},{"issue":"20","key":"4488_CR108","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1097\/00029330-200810020-00004","volume":"121","author":"TT Wang","year":"2008","unstructured":"Wang TT, Frezza EE, Ma R, Hu SY, Liu CZ, Zhang GY, Wachtel MS, Lu XM, Feng JB, Lu CX (2008) Loss expression of active fragile sites genes associated with the severity of breast epithelial abnormalities. Chin Med J 121(20):1969\u20131974","journal-title":"Chin Med J"},{"issue":"2","key":"4488_CR109","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/modpathol.3880503","volume":"15","author":"R Xu","year":"2002","unstructured":"Xu R, Perle MA, Inghirami G, Chan W, Delgado Y, Feiner H (2002) Amplification of Her-2\/neu gene in Her-2\/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material. Mod Pathol 15(2):116\u2013124","journal-title":"Mod Pathol"},{"issue":"1","key":"4488_CR110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.17305\/bjbms.2012.2533","volume":"12","author":"F Eren","year":"2012","unstructured":"Eren F, Calay Z, Durak H, Eren B, Comunoglu N, Aydin O (2012) C-Erb-b2 oncogene expression in intraductal proliferative lesions of the breast. Bosnian J Basic Med Sci 12(1):41\u201350","journal-title":"Bosnian J Basic Med Sci"},{"issue":"2","key":"4488_CR111","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1590\/S1516-31802009000200003","volume":"127","author":"RC Mazzini","year":"2009","unstructured":"Mazzini RC, Elias S, Nazario AC, Kemp C, Logullo AF (2009) Prevalence of c-myc expression in breast lesions associated with microcalcifications detected by routine mammography. Sao Paulo Med J 127(2):66\u201370","journal-title":"Sao Paulo Med J"},{"issue":"4","key":"4488_CR112","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/(SICI)1096-9896(199804)184:4<396::AID-PATH1259>3.0.CO;2-G","volume":"184","author":"CE Gillett","year":"1998","unstructured":"Gillett CE, Lee AH, Millis RR, Barnes DM (1998) Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia. J Pathol 184(4):396\u2013400","journal-title":"J Pathol"},{"issue":"7","key":"4488_CR113","doi-asserted-by":"crossref","first-page":"e0132214","DOI":"10.1371\/journal.pone.0132214","volume":"10","author":"A Shi","year":"2015","unstructured":"Shi A, Dong J, Hilsenbeck S, Bi L, Zhang H, Li Y (2015) The status of STAT3 and STAT5 in human breast atypical ductal hyperplasia. PLoS ONE 10(7):e0132214","journal-title":"PLoS ONE"},{"issue":"9","key":"4488_CR114","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/ng1409","volume":"36","author":"K Chin","year":"2004","unstructured":"Chin K, de Solorzano CO, Knowles D, Jones A, Chou W, Rodriguez EG, Kuo WL, Ljung BM, Chew K, Myambo K, Miranda M, Krig S, Garbe J, Stampfer M, Yaswen P, Gray JW, Lockett SJ (2004) In situ analyses of genome instability in breast cancer. Nat Genet 36(9):984\u2013988","journal-title":"Nat Genet"},{"issue":"1","key":"4488_CR115","first-page":"229","volume":"4","author":"K Yashima","year":"1998","unstructured":"Yashima K, Milchgrub S, Gollahon LS, Maitra A, Saboorian MH, Shay JW, Gazdar AF (1998) Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma. Clin Cancer Res 4(1):229\u2013234","journal-title":"Clin Cancer Res"},{"issue":"8","key":"4488_CR116","first-page":"1221","volume":"115","author":"M Song","year":"2002","unstructured":"Song M, Mi X, Li B, Zhu J, Gao Y, Cui S, Song J (2002) Expression of telomerase genes in cancer development in atypical hyperplasia of the mammary duct. Chin Med J 115(8):1221\u20131225","journal-title":"Chin Med J"},{"issue":"6","key":"4488_CR117","first-page":"923","volume":"2","author":"H Guan","year":"2009","unstructured":"Guan H, Sun Y, Zan Q, Xu M, Li Y, Zhou J, He E, Eriksson S, Wen W, Skog S (2009) Thymidine kinase 1 expression in atypical ductal hyperplasia significantly differs from usual ductal hyperplasia and ductal carcinoma in situ: a useful tool in tumor therapy management. Mol Med Rep 2(6):923\u2013929","journal-title":"Mol Med Rep"},{"issue":"2","key":"4488_CR118","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0046-8177(97)90109-X","volume":"28","author":"CL Rosenberg","year":"1997","unstructured":"Rosenberg CL, Larson PS, Romo JD, de las MA, Faller DV (1997) Microsatellite alterations indicating monoclonality in atypical hyperplasias associated with breast cancer. Hum Pathol 28(2):214\u2013219","journal-title":"Hum Pathol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-017-4488-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4488-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4488-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T12:52:47Z","timestamp":1570107167000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-017-4488-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,14]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["4488"],"URL":"https:\/\/doi.org\/10.1007\/s10549-017-4488-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,14]]}}}